Worldwide President, Surgical
Johnson & Johnson Vision
Thomas Frinzi is Worldwide President, Surgical, Johnson & Johnson Vision, which includes a broad ophthalmology portfolio across the areas of cataracts and refractive surgery. Tom was appointed to his position in February 2017 at the conclusion of J&J’s acquisition of Abbott Medical Optics. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott’s vision business. Prior to joining Abbott, Mr. Frinzi held leadership positions in ophthalmology and medical device companies. Most recently, as President and CEO of WaveTec Vision, developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. He earned a bachelor’s degree in political science from University of Tampa.